Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy
NCT ID: NCT02747550
Last Updated: 2019-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2016-05-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3-dimensional Versus 2-dimensional Laparoscopy for Myomectomy
NCT04070716
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
NCT04519593
Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.
NCT03570879
Hand-assisted Laparoscopic Surgery (HALS) for Myomectomy
NCT01858454
Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.
NCT06882824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LM with TESTO
In subjects allocated to the experimental group, the temporary simultaneous two-arterial occlusions (TESTO) procedure was performed to minimize operative blood loss during laparoscopic myomectomy.
LM with TESTO
In subjects allocated to the experimental group, the temporary simultaneous two-arterial occlusions (TESTO) procedure was performed to minimize operative blood loss during laparoscopic myomectomy.
LM without TESTO
In the control group, no intervention for the temporary simultaneous two-arterial occlusions (TESTO) procedure was made during laparoscopic myomectomy.
LM without TESTO
In the control group, no intervention for the temporary simultaneous two-arterial occlusions (TESTO) procedure was made during laparoscopic myomectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LM with TESTO
In subjects allocated to the experimental group, the temporary simultaneous two-arterial occlusions (TESTO) procedure was performed to minimize operative blood loss during laparoscopic myomectomy.
LM without TESTO
In the control group, no intervention for the temporary simultaneous two-arterial occlusions (TESTO) procedure was made during laparoscopic myomectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women who were planning to undergo laparoscopic myomectomy
* women who had ≤ 10 myomas, with the largest myoma ≤ 10 cm
* women with regular menstrual bleeding
* women who were not pregnant at the surgery
* women between 19 and 48 years of age.
Exclusion Criteria
* women who were in postmenopausal or climacteric status
* women with a history of oophorectomy or salpingo-oophorectomy
* women with any suggestion of malignant uterine or adnexal diseases
* women with major medical comorbidities or psychiatric illnesses, which could affect follow-up and/or compliance
* women who refused to participate or give consent to the procedures
19 Years
48 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kangbuk Samsung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taejong Song
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Taejong Song, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Kangbuk Samsung Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kangbuk Samsung Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-04-053
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.